,Date,Title,URL,Journal,Severe,Severe lower bound,Severe upper bound,Severe p-value,Severe Significant,Severe Adjusted,Severe Calculated,Fatality,Fatality lower bound,Fatality upper bound,Fatality p-value,Fatality Significant,Fatality Adjusted,Fatality Calculated,Multivariate adjustment,Design,Sample,Study population,Added on,Critical only,Discharged vs. death?,Sample Text,Matches,Entry
,2020-08-31,"Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations",https://doi.org/10.1016/j.dsx.2020.04.004,Diabetes & Metabolic Syndrome: Clinical Research & Reviews,,,,,,,,,,,,,,,,Retrospective observational,161.0,"Methods PubMed database and Google Scholar were searched using the key terms ‘COVID-19’, ‘SARS-CoV-2’, ‘diabetes’, ‘antidiabetic therapy’ up to April 2, 2020.",,,,A study in 161 patients with COVID-19 in Wuhan found increased time for viral clearance in patients with diabetes .,"the odds ratio (OR) of severe COVID-19 was not significantly higher in patients with diabetes (OR, 2.07; 95% CI, 0.89 to 4.82), unlike hypertension (OR, 2.36; 95% CI, 1.46 to 3.83) and CVD (OR, 3.42; 95% CI, 1.88 to 6.22).

found diabetes to have an OR of 2.85 (95% CI, 1.35 to 6.05; p < 0.001) for in-hospital mortality.

demonstrated a HR of 1.58 (95% CI, 0.80 to 3.13, p = 0.19) for death in patients with diabetes with COVID-19.

showed metformin users had a significantly lower risk of death (HR, 0.46; 95% CI, 0.23 to 0.92), compared with non-metformin users, in patients with coexistent chronic obstructive pulmonary disease and diabetes.

found a significant correlation between COVID-19 severity and diabetes (OR, 2.67, 95% CI; 1.91 to 3.74; p < 0.01).

found that diabetic patients had a hazard ratio (HR) of 2.34 (95% CI, 1.35 to 4.05; p = 0.002) for acute respiratory syndrome (ARDS).

reported diabetes to be associated with 58.0% patient with COVID-19.

However, the CFR was as high as 10.5% in patients with CVD, 7.3% in diabetes and 6.0% in hypertension .",2020-05-12
,2020-08-31,Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers,https://doi.org/10.1016/j.dsx.2020.03.016,Diabetes & Metabolic Syndrome: Clinical Research & Reviews,,,,,,,,,,,,,,,,Retrospective observational,187.0,"Methods We have systematically searched the medical database up to March 27, 2020 and retrieved all the published articles in English language related to our topic using MeSH key words.",,,,"In a study of 187 patients with COVID-19, Guo et al.","found hypertension to have an odds ratio (OR) of 3.05 (95% CI, 1.57 to 5.92; p < 0.006), diabetes with OR of 2.85 (95% CI, 1.35 to 6.05; p < 0.001), whereas presence of coronary artery disease had an OR of 21.40 (95% CI, 4.64 to 98.76; p < 0.0001) for in-hospital mortality, in an univariate analysis .

found hypertension to have a hazard ratio (HR) of 1.82 (95% CI, 1.13 to 2.95; p ¼ 0.01) for acute respiratory distress syndrome (ARDS) and 1.70 (95% CI, 0.92 to 3.14, p ¼ 0.09) for death.

found hypertension to have a hazard ratio (HR) of 1.82 (95% CI, 1.13 to 2.95; p = 0.01) for acute respiratory distress syndrome (ARDS) and 1.70 (95% CI, 0.92 to 3.14, p = 0.09) for death.

The diabetic patients had a HR of 2.34 (95% CI, 1.35 to 4.05; p ¼ 0.002) for ARDS and HR of 1.58 (95% CI, 0.80 to 3.13, p ¼ 0.19) for death, in a bivariate cox regression analysis .

The diabetic patients had a HR of 2.34 (95% CI, 1.35 to 4.05; p = 0.002) for ARDS and HR of 1.58 (95% CI, 0.80 to 3.13, p = 0.19) for death, in a bivariate cox regression analysis .",2020-04-17
,2020-07-15,Myocardial injury and COVID-19: Possible mechanisms,https://doi.org/10.1016/j.lfs.2020.117723,Life Sci,,,,,,,,,,,,,,,,Cross-sectional,419.0,"in a single center in Wuhan, China examined mortality associated with CVD comorbidity and troponin T (TnT) elevation on admission .",,,,"In another case-series of 419 cases with COVID-19 in Shenzhen, China, patients were divided into 36 ICU patients and 383 non-ICU patients.","A meta-analysis of 637 cases of MERS identified the prevalence of CVD, hypertension, and diabetes to be 30%, 50%, and 50% respectively .

of 1527 patients mostly in Wuhan, China indicated the prevalence of hypertension, cardiac and cerebrovascular disease, and diabetes to be 17.1%, 16.4%, and 9.7% respectively amongst patients with COVID-19.",2020-05-12
,2020-06-30,Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review,https://doi.org/10.1016/j.jcv.2020.104380,Journal of Clinical Virology,,,,,,,,,,,,,,,,Systematic review,4.0,"A literature search was conducted on PubMed, Embase, Scopus, and Web of Science for articles published until April 9, 2020 using keywords such as ""COVID-19,"" ""tocilizumab,"" ""interleukin 6,"" or ""IL-6.""",,,,Four patients were identified that received TCZ that were diagnosed with COVID-19 [ ].,"The chronic illnesses of the patient population included hypertension, diabetes mellitus (DM), and stroke.",2020-05-12
,2020-06-30,Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis,https://doi.org/10.1016/j.jcv.2020.104371,Journal of Clinical Virology,,,,,,,,,,,,,,,,Systematic review,21.0,"Methods Medline, SinoMed, EMBASE, and Cochrane Library were searched for clinical and epidemiological studies on confirmed cases of COVID-19.",,,,"Twenty-one studies were selected, with a total of 47,344 patients (24,419 male and 22,925 females), representing approximately 40 % of the WHO confirmed.","The percentage of severe cases in diabetes and hypertension cases was 44.5 % (95CI 27.0-61.9 %) and (Fig.

The prevalence of diabetes and hypertension comorbidities was 7.7 % (95CI 6.1–9.3 %) and 15.6 % (95CI 12.6–18.6 %), respectively.

The prevalence of diabetes and hypertension comorbidities was 7.7 % (95CI 6.1-9.3 %) and 15.6 % (95CI 12.6-18.6 %), respectively.

The percentage of critical cases in diabetes and hypertension was 44.5 % (95CI 27.0–61.9 %) and 41.7 % (95CI 26.4–56.9 %), respectively.

The percentage of severe cases in diabetes and hypertension cases was 44.5 % (95CI 27.0–61.9 %) and 41.7 % (95CI 26.4–56.9 %), respectively (Fig.",2020-05-12
,2020-05-31,Outbreak of a new coronavirus: what anaesthetists should know,https://doi.org/10.1016/j.bja.2020.02.008,British Journal of Anaesthesia,,,,,,,,,,,,,,,,Other,251.0,"In December 2019, an outbreak of pneumonia of unknown origin developed in Wuhan of Hubei Province, China.",,,,"15 In Canada, a final count of 251 cases of SARS was confirmed; 43% of them were healthcare workers, the majority were from Toronto.","14 People with co-morbidities, such as diabetes mellitus and cardiovascular disease, appear to be at higher risk for death.",2020-05-12
,2020-05-07,Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States,https://doi.org/10.1016/j.cell.2020.04.021,Cell,,,,,,,,,,,,,,,,Other,168.0,"Daily COVID-19 cases from international locations were obtained from the European Centre for Disease Prevention and Control via Our World in Data ( International data were accessed on March 19, 2020.",,,,"The COVID-19 Outbreak in Connecticut Is Phylogenetically Linked to SARS-CoV-2 from Washington (A) We constructed a maximum-likelihood tree using 168 global SARS-CoV-2 protein coding sequences, including 9 sequences from COVID-19 patients identified in Connecticut from March 6-14, 2020.", : 0.092 (95% CI = 0.05-0.20).,2020-05-12
,2020-05-06,Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis,https://doi.org/10.1016/j.dsx.2020.04.044,Diabetes & Metabolic Syndrome: Clinical Research & Reviews,,,,,,,,,,,,,,,,Systematic review,1724.0,"Methods We searched the PubMed for case-control studies in English, published between Jan 1 and Apr 22, 2020, that had data on diabetes in patients with COVID-19.",,,,"Diabetes was present in 1,724 patients out of total 16,003 patients of COVID-19.","The recalculated pooled odds ratio of association of diabetes mellitus with severe clinical course of COVID-19 was 2.26 (95% CI: 1.78-2.87; p<0.01) (Supplementary Figure 5) .

Diabetes was also associated with severe COVID-19 with a pooled odds ratio of 2.75 (95% CI: 2.09–3.62; p < 0.01).

To study the prevalence of diabetes mellitus in patients with COVID-19, pooled proportion and 95% confidence interval (CI) was taken as the effect size.

Presence of diabetes was found to be significantly associated with severe COVID-19 (pooled odds ratio 2.75 [95% CI: 2.09-3.62; p<0.01]) as well as mortality due to COVID-19 (pooled odds ratio 1.90 [95% CI: 1.37-2.64; p<0.01]).

Results We included 33 studies (16,003 patients) and found diabetes to be significantly associated with mortality of COVID-19 with a pooled odds ratio of 1.90 (95% CI: 1.37–2.64; p < 0.01).

The pooled prevalence of diabetes in patients with COVID-19 was 9.8% (95% CI: 8.7%–10.9%) (after adjusting for heterogeneity).

The secondary outcome of interest was to study the prevalence of diabetes mellitus in patients with COVID-19.",2020-05-12
,2020-05-05,Risk Factors of the Severity of COVID-19: A Meta-Analysis,https://doi.org/10.1101/2020.04.30.20086744,medrxiv,,,,,,,,,,,,,,,,Systematic review,2272.0,"Both of the authors searched through PubMed, Google Scholar, EMBASE, and Cochrane Library using keywords:",,,,We have extracted 2272 patients' information from 10 autonomous studies 14-23 and incorporated them into this research.,"This study found sex (male) (Risk ratio [RR] =1.29, 95% CI, 1.07 to 1.54), hypertension (RR=1.79, 95% CI, 1.57 to 2.04), diabetes (RR=1.57, 95% CI, 1.25 to 1.98), fatigue or myalgia (RR=1.17, 95% CI, 1.02; 1.35), and smoking history (RR=1.71, 95% CI,1.25; 2.35) are potential risk factors for the severity of COVID-19.",2020-05-12
,2020-05-05,The Utility of rRT-PCR in Diagnosis and Assessment of Case-fatality rates of COVID-19 In the Iranian Population. Positive Test Results are a Marker for Illness Severity,https://doi.org/10.1101/2020.04.29.20085233,medrxiv,,,,,,,,,,,,,,,,Case series,96103.0,We conducted data analysis March through April 2020.,,,,96103 patients were tested from 879 hospitals.,"More patients had cardiovascular diseases (10.6% vs. 9.5%, p<0.001) and type 2 diabetes mellitus (10.8% vs. 8.7%, p<0.001) among COVID-19 positive vs. negative patients.",2020-05-12
,2020-05-02,Modifiable and non-modifiable risk factors for COVID-19: results from UK Biobank,https://doi.org/10.1101/2020.04.28.20083295,medrxiv,,,,,,,,,,,,,,,,Case series,1474.0,March 2020 to 14th April 2020.,,,,"Results were available for 2,724 tests conducted on 1,474 individuals.","Among comorbidities, risk factors included longstanding illness (RR 1.65 (95% CI 1.32-2.06)), diabetes, CVD and statin use.

  socioeconomic deprivation (RR 1.26 (95% CI 1.14-1.40)), longstanding illness (RR 1.38 (95% CI 1.09-1.74)), lower HDL-cholesterol (RR 0.82 (95% CI 1.72-0.95)) and higher cystatin C (RR 1.24 (95% CI 1.12-1.37)) ( Table 2) .

Other risk factors were older age (RR 1.15 per 5 years (95% CI 1.08-1.24)), male sex (RR 1.54 (95% CI 1.24-1.91)), black ethnicity (RR 2.07 (95% CI 1.16, 3.71)), socioeconomic deprivation (RR 1.35 per SD increase in Townsend Index (95% CI 1.23-1.49)).

Other risk factors included older age (RR 1.10 per 5 year increase (95% CI 1.02-1.36)), male sex (RR 1.64 (95% CI 1.25-2.14)), black ethnicity (RR 1.86 (95% CI 1.03, 3.36)), All rights reserved.

After adding BMI, blood pressure, FEV1 and walking pace as covariates, modifiable risk factors for COVID-19 admission continued to include smoking (RR 1.38 (95% CI 1.11-1.73)), higher BMI (RR 1.24 (95% CI 1.12-1.38)), use of blood pressure lowering medication as a proxy for hypertension (RR 1.40 95% CI 1.08-1.82) and slow walking pace (RR 1.66 (95% CI 1.20-2.30)).",2020-05-12
,2020-05-01,"Racial, Economic and Health Inequality and COVID-19 Infection in the United States",https://doi.org/10.1101/2020.04.26.20079756,medrxiv,,,,,,,,,,,,,,,,Cross-sectional,1981.0,"Data source: Data sources in this study include, 1) publicly available data from USAfacts and the US Census Bureau for COVID-19 cases and county-level demographic data, 9, 10 2) COVID-19 data reported by each state on their department of health websites, 9 3) State Population by Race/Ethnicity data, 11, 12 and 4) mobility data extracted from Google.",,,,"African Americans were more vulnerable to COVID-19 than other ethnic groups (1,981 African American infected cases versus 658 Whites per million).","CI: -0.41, -0.12, q<0.003).",2020-05-12
,2020-05-01,High frequency of SARS-CoV-2 RNAemia and association with severe disease,https://doi.org/10.1101/2020.04.26.20080101,medrxiv,,,,,,,,,,,,,,,,Cross-sectional,7240.0,Methods: An analytical cross-sectional study was performed in a single-center tertiary care institution in northern California and included consecutive inpatients and outpatients with COVID-19 confirmed by detection of SARS-CoV-2 RNA in nasopharyngeal swab specimens.,,,,"A total of 7,240 samples from SHC patients were tested for SARS-CoV-2 corresponding to 4,485 82 outpatients, 2,452 ED patients, and 303 inpatients, and 453 (6.3%) were positive.","Comorbidities were frequent including obesity (37.7%), hypertension (30.6%) and diabetes mellitus (22.4%).",2020-05-12
,2020-04-29,Type I IFN immunoprofiling in COVID-19 patients,https://doi.org/10.1016/j.jaci.2020.04.029,Journal of Allergy and Clinical Immunology,,,,,,,,,,,,,,,,Other,3.0,"Contamines, Haute Savoie, France) in February 2020.",,,,"Firstly, we explored three patients issued from the first COVID cluster diagnosed in France (Les 66",Diabetes (n (%)) 1 (20%) 3(14%),2020-05-01
,2020-04-28,Marked Up-Regulation of ACE2 in Hearts of Patients with Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2-Mediated COVID-19,https://doi.org/10.1016/j.mayocp.2020.04.028,Mayo Clinic Proceedings,,,,,,,,,,,,,,,,Other,106.0,"All patients undergoing therapeutic surgical septal myectomy for symptomatic relief of obstructive HCM between January 1, 1999 and December 31, 2010 were eligible for inclusion in this study.",,,,Patients and Methods RNA was extracted from cardiac tissue flash frozen at therapeutic surgical septal myectomy for 106 patients with HCM and from 39 healthy donor hearts.,"A large meta-analysis of over 46,000 patients in China showed the most common co-morbidities were HTN (17±7%, 95% CI 14 -22%), diabetes mellitus (8±6% 95% CI 6-11%), and cardiovascular disease (5±4%, 95% CI 4-7%) 31 .",2020-05-01
,2020-04-28,Health Insurance Status and Risk Factors for Poor Outcomes With COVID-19 Among U.S. Health Care Workers: A Cross-sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197038/,Ann Intern Med,,,,,,,,,,,,,,,,Cross-sectional,,Moderate/severe asthma = Had an asthma attack in past 12 mo or had an emergency department visit for asthma in past 12 mo or used more than 3 canisters or disks of inhalers in past 3 mo.,,,,Moderate/severe asthma = Had an asthma attack in past 12 mo or had an emergency department visit for asthma in past 12 mo or used more than 3 canisters or disks of inhalers in past 3 mo.,"Of these highrisk persons, 275 000 (CI, 154 000 to 396 000), or 7.5% (CI, 4.2% to 10.8%), were uninsured, including 11.4% (CI, 4.6% to 18.2%) of those with diabetes and 20.8% (CI, 13.8% to 27.8%) of those with chronic lung disease other than asthma.",2020-05-12
,2020-04-25,COVID-19 Fatality and Comorbidity Risk Factors among Confirmed Patients in Mexico,https://doi.org/10.1101/2020.04.21.20074591,medrxiv,,,,,,,,,,,,,,,,Other,7497.0,"In this paper we estimate fatality risks based on survival analysis methods, calculated from individual-level data on symptomatic patients confirmed with COVID-19 recently released by the Mexican Ministry of Health.",,,,"Our analysis is based on 7,497 patients who tested positive for COVID-19 in Mexico, a subset of a larger dataset of 49,167 patients with COVID-19 related symptoms who sought attention in medical units and were tested with positive, negative (29,301 cases) and pending (12,369 cases) results.","In contrast, high blood pressure increases the estimated hazard by 38% (HR=1.378, 95% CI: 1.086-1.749), immune suppression by 70% (HR=1.696, 95% CI: 1.148-2.505), diabetes by 73% (HR=1.730, 95% CI: 36.0-120.2), COPD by 77% (HR=1.770, 95% CI: 1.269-2.469), obesity by 78% (HR=1.776, 95% CI: 1.415-2.231), and chronic liver disease by 168% (HR=2.679, 95% CI: 1.789-4.014).",2020-05-01
,2020-04-22,Coronavirus Disease (COVID-19) Pandemic: An Overview of Systematic Reviews,https://doi.org/10.1101/2020.04.16.20068213,medrxiv,,,,,,,,,,,,,,,,Systematic review,1063.0,"Methods: Nine databases (Medline, EMBASE, Cochrane Library, CINAHL, Web of Sciences, PDQ-Evidence, WHO's Global Research, LILACS and Epistemonikos) were searched from December 1, 2019 to March 24, 2020.",,,,"Our search retrieved 1,063 publications, of which 175 were duplicates.","The most common comorbidities were hypertension (17±7, 95% CI 14-22%), diabetes (8±6, 95% CI 6-11%), cardiovascular diseases (5±4, 95% CI 4-7%) and respiratory system diseases (2±0, 95% CI 1-3%).

There was a higher likelihood that patients with severe disease had hypertension (OR 2.36, 95% CI: 1.46-3.83), respiratory disease (OR 2.46, 95% CI: 1.76-3.44), or cardiovascular disease (OR 3.42, 95% CI: 1.88-6.22), compared with patients with non-severe disease.

The most prevalent comorbidities among confirmed cases of COVID-19 were hypertension (17.1%), cardiocerebrovascular disease (16.4%) and diabetes (9.7%).",2020-05-01
,2020-04-19,Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187729/,Research (Wash D C),,,,,,,,,,,,,,,,Systematic review,41.0,"The databases PubMed, Embase, Web of Science, medRxiv, and bioRxiv were searched for all articles published through April 6, 2020, with no language restrictions, using the following keywords: “2019-nCoV” OR “SARS-CoV-2” OR “COVID-19” OR “new coronary pneumonia” OR “corona virus” OR “novel coronavirus” OR “nCoV”.",,,,"based on a report from Jinyintan Hospital in Wuhan, China , which included 41 laboratory-confirmed COVID-19 cases; five of these 41 patients (12%) had ACI, and four of these five patients (80%) were admitted to the ICU.","Our analysis revealed that compared to COVID-19 patients with no preexisting chronic cardiovascular condition, COVID-19 patients who present with either hypertension or CVD have an approximately 3-4-fold higher risk of developing severe disease, with an odds ratio (OR) of 2.92 (95% CI: 2.35, 3.64) and 3.84 (95% CI: 2.90, 5.07), respectively (Figure 3).

Our analysis revealed that compared to COVID-19 patients with no preexisting chronic cardiovascular condition, COVID-19 patients who present with either hypertension or CVD have an approximately 3-4-fold higher risk of developing severe disease, with an odds ratio (OR) of 2.92 (95% CI: 2.35, 3.64) and 3.84 (95% CI: 2.90, 5.07), respectively ( Figure 3 ).

showing that both preexisting diabetes (OR: 3.0; 95% CI: 1.4, 6.3) and preexisting hyperglycemia (OR: 3.3; 95% CI: 1.4, 7.7) were independent predictors of SARS-related death .",2020-05-12
,2020-04-19,Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease,https://doi.org/10.1016/j.metabol.2020.154244,Metabolism,,,,,,,,,,,,,,,,Other,214.0,"We consecutively enrolled 214 patients with laboratory-confirmed COVID-19 aged between 18 and 75 years from three hospitals in Wenzhou, China (the First Affiliated Hospital of Wenzhou Medical University, Wenzhou Central Hospital, and Ruian People's Hospital) between January 1, 2020 and February 29, 2020.",,,,"Methods 214 patients with laboratory-confirmed COVID-19 aged between 18 and 75 years from three hospitals in Wenzhou, China were consecutively enrolled.","Notably, this association with obesity and COVID-19 severity remained significant (adjusted-OR 6.32, 95% CI 1.16–34.54, p = .033) even after adjusting for age, sex, smoking, diabetes, hypertension, and dyslipidaemia.

Results The presence of obesity in MAFLD patients was associated with a ~ 6-fold increased risk of severe COVID-19 illness (unadjusted-OR 5.77, 95% CI 1.19–27.91, p = .029).",2020-04-24
,2020-04-16,Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis,https://doi.org/10.1101/2020.04.12.20062869,medrxiv,,,,,,,,,,,,,,,,Systematic review,3473.0,"Searched Databases included PubMed, Embase, Scopus, Web of Science, Cochrane Library, medRxiv pre-print database as well as Science Direct search engine.",,,,Results: Sixteen papers including 3473 patients entered into meta-analysis for ICU admission and mortality outcome and fifty-nine papers including 9509 patients for descriptive outcomes.,"Results of meta-analysis indicated that acute cardiac injury, (OR: 15.94, 95% CI 2.31-110.14), hypertension (OR: 1.92, 95% CI 1.92-2.74), heart Failure (OR: 11.73, 95% CI 5.17-26.60), other cardiovascular disease (OR: 1.95, 95% CI 1.17-3.24) and overall CVDs (OR: 3.37, 95% CI 2.06-5.52) were significantly associated with mortality in COVID-19 patients.

Results of meta-analysis indicated that acute cardiac injury (OR: 15.94, 95% CI 2.31-110.14), Hypertension (OR: 1.92, 95% CI 1.92-2.74), Heart Failure (OR: 11.73, 95% CI 5.17-26.60), other cardiovascular disease (OR: 1.95, 95% CI 1.17-3.24) and overall CVDs (OR: 3.37, 95% CI 2.06-5.52) were significantly associated with mortality in COVID-19 patients.

Odds of mortality of COVID-19 patients with heart failure was significantly higher than hypertension and other cardiovascular diseases ( Table 2) .",2020-04-24
,2020-04-13,"Nosocomial infection among patients with COVID-19: A retrospective data analysis of 918 cases from a single center in Wuhan, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180328/,PMC,,,,,,,,,,,,,,,,Retrospective observational,918.0,"We retrospectively analyzed the clinical data of 918 COVID-19 patients in Tongji Hospital from December 30, 2019, to February 29, 2020.",,,,"We retrospectively analyzed the clinical data of 918 COVID-19 patients in Tongji Hospital from December 30, 2019, to February 29, 2020.","Among these factors, the highest odds ratio was for invasive devices (OR, 4.62; 95% CI, 2.47–8.62) followed by diabetes (OR, 3.04; 95% CI, 1.38–6.69), combination of antibiotics (OR, 3.02; 95% CI, 1.10–8.26), glucocorticoid treatment (OR, 2.44; 95% CI, 1.36–4.37), and hematological disease (OR, 1.95; 95% CI, 1.01–1.06).

In total, 40 of 65 patients (65.6%) in the case group had comorbidities; the most prevalent of these were hypertension (36.9%), cardiovascular disease (18.5%), and diabetes (18.5%).

Significant predictors of nosocomial infection after adjustment for other covariates were invasive devices (OR, 4.28; 95% CI, 2.47–8.61; P =.007) followed by diabetes (OR,: 3.06, 95% CI, 1.41–7.22; P =.037), and combination of antibiotics (OR, 1.84, 95% CI, 1.31–4.59; P = .003) (Supplementary Table 1 online).

Significant predictors of nosocomial infection after adjustment for other covariates were invasive devices (OR, 4.28; 95% CI, 2.47-8.61; P =.007) followed by diabetes (OR,: 3.06, 95% CI, 1.41-7.22; P =.037), and combination of antibiotics (OR, 1.84, 95% CI, 1.31-4.59; P = .003) (Supplementary Table 1 online).",2020-05-01
,2020-04-11,"Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City",https://doi.org/10.1101/2020.04.08.20057794,medrxiv,,,,,,,,,,,,,,,,Cross-sectional,4103.0,"Methods: We conducted a cross-sectional analysis of all patients with laboratory-confirmed Covid-19 treated at a single academic health system in New York City between March 1, 2020 and April 2, 2020, with follow up through April 7, 2020.",,,,"Results: Among 4,103 Covid-19 patients, 1,999 (48.7%) were hospitalized, of whom 981/1,999 (49.1%) have been discharged home, and 292/1,999 (14.6%) have died or were discharged to hospice.","Strongest hospitalization risks were age ≥75 years (OR 66.8, 95% CI, 44.7-102.6), age 65-74 (OR 10.9, 95% CI, 8.35-14.34), BMI>40 (OR 6.2, 95% CI, 4.2-9.3), and heart failure (OR 4.3 95% CI, 1.9-11.2).

In multivariable analysis, the factors most associated with hospitalization were age 75 years or older (OR 66.8, 95% CI, 44.7 to 102.6), age 65-74 (OR 10.9, 95% CI, 8.35 to 14.34), 1 1 BMI>40 (OR 6.2, 95% CI, 4.2-9.3), and history of heart failure (OR 4.3 95% CI, 1.9-11.2).

A total of 614 (15.0%) had diabetes, 1,100 (26.8%) obesity, and 1,235 (30.1%) cardiovascular disease.",2020-04-17
,2020-04-09,COVID-19 and Diabetes: Knowledge in Progress,https://doi.org/10.1016/j.diabres.2020.108142,Diabetes Research and Clinical Practice,,,,,,,,,,,,,,,,Other,72314.0,"Methods We searched for articles in PubMed and Google Scholar databases till 02 April 2020, with the following keywords: “SARS-CoV-2”, “COVID-19”, “infection”, “pathogenesis”, “incubation period”, “transmission”, “clinical features”, “diagnosis”, “treatment”, “diabetes”, with interposition of the Boolean operator “AND”.",,,,"In a large Chinese report including 72,314 patients, only 2% of those infected were younger than 20 years old (20) .","One Chinese meta-analysis including 1527 patients showed that the most prevalent cardiovascular metabolic comorbidities with COVID-19 were hypertension (17.1%, 95% CI 9.9 -24.4%) and cardio-cerebrovascular disease (16.4%, 95% CI 6.6 -26.1%), followed by diabetes (9.7%, 95% CI 6.9 -12.5%).",2020-04-17
,2020-04-09,SARS-Cov-2 in Spanish Intensive Care: Early Experience with 15-day Survival In Vitoria,https://doi.org/10.1016/j.accpm.2020.04.001,Anaesthesia Critical Care & Pain Medicine,,,,,,,,,,,,,,,,Other,42.0,Methods: We identified patients from the two public hospitals in Vitoria who were admitted to ICU with confirmed infection by SARS-CoV-2.,,,,"Empirical antibiotic agents were administrated to 42 patients, whereas co-infection was identified in 6 patients.",Obesity Diabetes mellitus 23 (48%) 9 (19%) - 7 (33%) - - 10 (31%) -,2020-04-17
,2020-04-08,Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185114/,Aging (Albany NY),,,,,,,,,,,,,,,,Systematic review,1558.0,"A literature search was performed using the electronic platforms (PubMed, Cochrane Library, Embase, and other databases) to obtain relevant research studies published up to March 1, 2020.",,,,A total of 1558 patients with COVID-19 in 6 studies were enrolled in our meta-analysis eventually.,"The results find that COVID-19 patients with hypertension (OR: 2.29, 95% CI: 1.69-3.10, P<0.001) (Figure 2A), diabetes (OR: 2.47, 95% CI: 1.67-3.66, P<0.001) (Figure 2B), or COPD (OR: 5.97, 95% CI: 2.49-14.29, P<0.001) (Figure 2C) had a higher risk of exacerbation.

Inclusion criteria are as follows: Types of Studies: published studies reported the relationship between comorbidity and patients with COVID-19; Subjects: diagnosed patients with COVID-19; Exposure intervention: COVID-19 patients with comorbidity included: hypertension, diabetes, chronic obstructive pulmonary disease (COPD), liver disease, malignancy, renal disease, cardiovascular disease, cerebrovascular disease; Outcome indicator: the odds ratios (OR) with 95% confidence intervals (CI) for each comorbidity.

The meta-analysis identified hypertension, diabetes, COPD, cardiovascular disease, and cerebrovascular disease as significant risk factors for COVID-19 patients.

Hypertension, diabetes, COPD, cardiovascular disease, and cerebrovascular disease are major risk factors for patients with COVID-19.",2020-05-12
,2020-04-06,Widespread use of face masks in public may slow the spread of SARS CoV-2: an ecological study,https://doi.org/10.1101/2020.03.31.20048652,medrxiv,,,,,,,,,,,,,,,,Systematic review,500.0,Countries with missing data were dropped from the analyses.,,,,"Secondly, we only included countries 155 with at least 500 cumulative cases and countries whose first case was reported 156 before 7 March 2020.","0.07, 95% CI 0.05-0.08, P<0.001).

-326, 95% CI -601- -51, P=0.021).",2020-04-10
,2020-04-04,Is the ACE2 Overexpression a Risk Factor for COVID-19 Infection?,https://doi.org/10.1016/j.arcmed.2020.03.011,Archives of Medical Research,,,,,,,,,,,,,,,,Other,72.0,"The prevalence of hypertension in the Chinese adult population $18 years of age based on the 2017 American College of Cardiology/American Heart Association guideline is 46.4%, and increased in relation to age, reaching 78.7% in the population $75 years .",,,,"In the report of 72 314 patients infected with the novel coronavirus disease in China, a higher proportion of patients with severe disease were found in older persons with comorbidities such as cardiovascular disease, diabetes mellitus, or hypertension (1) .","In the report of 72 314 patients infected with the novel coronavirus disease in China, a higher proportion of patients with severe disease were found in older persons with comorbidities such as cardiovascular disease, diabetes mellitus, or hypertension .",2020-04-17
,2020-04-01,Forecasting the CoViD19 Diffusion in Italy and the Related Occupancy of Intensive Care Units,https://doi.org/10.1101/2020.03.30.20047894,medrxiv,,,,,,,,,,,,,,,,Modeling,6355.0,"This paper employs the data related to COVID-19, collected and regularly updated by the Italian National Institute of Health (an agency of the Italian Ministry of Health) and by the Italian Civil Protection Department.",,,,"• The remaining southern regions (Abruzzo, Molise, Puglia, Basilicata, Calabria, Sicily and Sardinia) will show an upward trend in the number of future positive cases lasting until 6 April, where 6355 cases are predicted.",", 10) and CI * U (h = 2, .",2020-04-10
,2020-03-30,Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up,https://doi.org/10.1016/j.jinf.2020.03.019,Journal of Infection,,,,,,,,,,,,,,,,Retrospective observational,339.0,"Methods Consecutive cases over 60 years old with COVID-19 in Renmin Hospital of Wuhan University from Jan 1 to Feb 6, 2020 were included.",,,,"Results 339 patients with COVID-19 (aged 71±8 years,173 females (51%)) were enrolled, including 80 (23.6%) critical, 159 severe (46.9%) and 100 moderate (29.5%) cases.","Symptoms of dyspnea (HR 2.35, CI 1.43-3.87, P = 0.001) and comorbidities including cardiovascular disease (HR 2.87, CI 1.70-4.83, P < 0.001), cerebrovascular disease (HR 3.26, CI 1.66-6.40, P = 0.001) and COPD (HR 3.72, CI 1.94-7.13, P < 0.001) were all predictive of fatal outcomes.

Common comorbidities were hypertension (40.8%), diabetes (16.0%) and cardiovascular disease (15.7%).

Common comorbidities included hypertension (138 cases, 40.8%), diabetes (54 cases, 16.0%) and cardiovascular disease (48 cases, 14.2%).",2020-04-17
,2020-03-30,Clinical and Paraclinical Characteristics of COVID-19 patients: A systematic review and meta-analysis,https://doi.org/10.1101/2020.03.26.20044057,medrxiv,,,,,,,,,,,,,,,,Systematic review,49504.0,"We searched databases of Web of Science, Scopus, and PubMed without any time limitation for publications up to March 13, 2020.",,,,"Out of selected papers, a total of 49504 patients infected with CoVID-19 with age ranged between 40 to 58 years old were included in our investigation.","Overall prevalence of these symptoms was 24% (95% CI, 13-34), 19% (95% CI, 11-27), 27% (95% CI, 12-42), 31% (95% CI, 14-48), 6% (95% CI, 2-9), 1% (95% CI, 0-2) and 6% (95% CI, 3-8) (Supplementary File and Table 2 ).

The meta-analysis showed that the prevalence of the underlying diseases like cardiovascular disease, diabetes, cerebrovascular disease and hypertension in COVID-19 patients were 4%, 6%, 1%, 14%, respectively.

Meta-analysis findings are as follows respectively: 84% (95% CI, 79-88), 65% (95% CI, 59-71), and 14% (95% CI 8-19) ( Fig.",2020-04-03
,2020-03-27,"A New Predictor of Disease Severity in Patients with COVID-19 in Wuhan, China",https://doi.org/10.1101/2020.03.24.20042119,medrxiv,,,,,,,,,,,,,,,,Retrospective observational,393.0,"Methods: Patients enrolled in this study were all hospitalized with COVID-19 in the Central Hospital of Wuhan, China.",,,,"Between January 1 and February 28, 2020, a total of 393 patients with COVID-19 were enrolled, but only 377 eligible participants were finally included in our analysis.","The independent risk factors for severe pneumonia were age [odds ratio (OR): 1.059, 95% confidence interval (CI): 1.036-1.082; p < 0.001], N/L (OR: 1.322, 95% CI: 1.180-1.481; p < 0.001), CRP (OR: 1.231, 95% CI: 1.129-1.341; p = 0.002), and D-dimer (OR: 1.059, 95% CI: 1.013-1.107; p = 0.011).

1.036-1.082; p < 0.001], N/L (OR: 1.322, 95% CI: 1.180-1.481; p < 0.001), CRP (OR: 1.231, 95% CI: 1.129-1.341; p = 0.002), and D-dimer (OR: 1.059, 95% CI: 1.013-1.107l p = 0.001) ( Table 2) .",2020-04-03
,2020-03-26,"COVID-19 clinical characteristics, and sex-specific risk of mortality: Systematic Review and Meta-analysis",https://doi.org/10.1101/2020.03.24.20042903,medrxiv,,,,,,,,,,,,,,,,Systematic review,4789.0,"Methods: We reviewed the scientific literature published from January 1, 2019 to March 3, 2020.",,,,A total of 4789 patients with a mean age of 49 years were evaluated.,"The most common comorbidities were respectively hypertension (18.5 %, CI 12.7-24.4), 246 cardiovascular diseases (14.9 %, CI 6.0-23.8), diabetes (10.8 %, CI 8.3-13.3), chronic liver 247 disease (8.1, CI 4.6-11.6) and smoking (8.0%, CI 2.3-13.6) ( Table 3) .

The most prevalent comorbidities in our study were hypertension (18.5 %, CI 12.7-24.4) followed 307 by cardiovascular diseases (14.9 %, CI 6.0-23.8) and diabetes (10.8 %, CI 8.3-13.3).

The most prevalent comorbidities were hypertension (18.5 %, CI 12.7 to 24.4) and Cardiovascular disease (14.9 %, CI 6.0 to 23.8).

According 308 to a systematic review for comorbidities by Yang et al, hypertension (17 ± 7%, CI 14-22%) and 309 diabetes (8 ± 6%, CI 6-11%), followed by cardiovascular diseases (5 ± 4%, CI 4-7%) were the 310 most common comorbid findings .",2020-04-03
,2020-03-23,Chinese and Italian COVID-19 outbreaks can be correctly described by a modified SIRD model,https://doi.org/10.1101/2020.03.19.20039388,medrxiv,,,,,,,,,,,,,,,,Other,30000.0,"However, the data reported in for the Italian case are retrieved from , making the use of both the databases interchangeable.",,,,"This caused many deaths in Italy (>20,000) and many other are expected, overcoming 30,000 cases.",of 7.09 (90% CI: 5.84-8.35).,2020-05-01
,2020-03-12,Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis,https://doi.org/10.1016/j.ijid.2020.03.017,Int J Infect Dis,,,,,,,,,,,,,,,,Systematic review,576.0,"A systematic search was conducted on studies published from January 1, 2019 to February 25, 2020 in PubMed, EMBASE, and Web of Science databases.",,,,"As of February 25, 2020, a total of 1 576 participants were included in our meta-analysis.","The most prevalent comorbidities were hypertension (21.1%, 95% CI: 13.0–27.2%) and diabetes (9.7%, 95% CI: 7.2–12.2%), followed by cardiovascular disease (8.4%, 95% CI: 3.8–13.8%) and respiratory system disease (1.5%, 95% CI: 0.9–2.1%).

As shown in Figure 2 (inserts A, B, C, D), the most prevalent comorbidities were hypertension (21.1%, 95% CI: 13.0–27.2%) and diabetes (9.7%, 95% CI: 7.2–12.2%), followed by cardiovascular disease (8.4%, 95% CI: 3.8–13.8%) and respiratory system disease (1.5%, 95% CI: 0.9–2.1%).

As shown in Figure 2 (inserts A, B, C, D), the most prevalent comorbidities were hypertension (21.1%, 95% CI: 13.0-27.2%) and diabetes (9.7%, 95% CI: 7.2-12.2%), followed by cardiovascular disease (8.4%, 95% CI: 3.8-13.8%) and respiratory system disease (1.5%, 95% CI: 0.9-2.1%).

Higher risk of hypertension (OR 2.36, 95% CI: 1.46–3.83), respiratory system disease (OR 2.46, 95% CI: 1.76–3.44), and cardiovascular disease (OR 3.42, 95% CI: 1.88–6.22) were observed in the severe group.

Higher risk of hypertension (OR 2.36, 95% CI: 1.46-3.83), respiratory system disease (OR 2.46, 95% CI: 1.76-3.44), and cardiovascular disease (OR 3.42, 95% CI: 1.88-6.22) were observed in the severe group.

When compared between severe and non-severe patients, the pooled OR of hypertension, respiratory system disease, and cardiovascular disease were 2.36 (95% CI: 1.46–3.83), 2.46 (95% CI: 1.76–3.44) and 3.42 (95% CI: 1.88–6.22) respectively.

The comorbidities included hypertension, diabetes, respiratory system disease, and cardiovascular disease.",2020-05-12
,2020-03-08,"Exploring diseases/traits and blood proteins causally related to expression of ACE2, the putative receptor of 2019-nCov: A Mendelian Randomization analysis",https://doi.org/10.1101/2020.03.04.20031237,medrxiv,,,,,,,,,,,,,,,,Other,1590.0,"ACE2 protein levels appear to be relatively well-correlated with mRNA levels across tissues, based on the Human Proteome Atlas ( We retrieved GWAS summary data from the GTEx database, one of the largest databases to date with both genotype and expression data for a large variety of tissues.",,,,"recently carried out a nationwide analysis of 1,590 patients with laboratory-confirmed COVID-19 and suggested that cancer patients might have a higher infection risk than those without 39 .","As shown in Table S1 , a number of COVID-19 cases (~5.4%) were also comorbid with diabetes mellitus (DM).",2020-03-27
,2020-03-06,Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing,https://doi.org/10.1101/2020.03.04.20030916,medrxiv,,,,,,,,,,,,,,,,Other,3.0,"According to the unified form, two residents collected clinical data from medical records separately.",,,,"Laboratory findings of 3 patients with COVID-19 Normal range case1 case2 case3 white blood cell count,x10 9 /L 3.5-9.5 5.0 6.3 4.0 neutrophil count,x10 9 /L 1.9-7.2 3.7 4.1 3.4",2 patients had diabetes and hypertension respectively.,2020-03-27
,2020-02-28,Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease,https://doi.org/10.1097/cm9.0000000000000775,Chin Med J (Engl),,,,,,,,,,,,,,,,Other,11.0,"Patients included in the study had been diagnosed with COVID-19 associated pneumonia between December 30, 2019, and January 15, 2020 , and hospitalized at one of three tertiary hospitals in Wuhan for over two weeks.",,,,"A total of 11 patients (14.1%) were included in the progression group, and 67 patients (85.9%) were included in the improvement/stabilization group.","The results of univariate logistic analysis found that age (OR, 10.575; 95% CI: 2.095–53.386; P = 0.004), history of smoking (OR, 12.187; 95% CI: 1.762–84.306; P = 0.011), maximum body temperature at admission (OR, 9.709; 95% CI: 1.176–83.330; P = 0.035), respiratory failure (OR, 8.021; 95% CI: 2.022–31.821; P = 0.003), severe illness (OR, 4.651; 95% CI: 0.930–23.250; P = 0.061), albumin (OR, 12.536; 95% CI: 2.409–65.233; P = 0.003), creatinine (OR, 6.800; 95% CI: 1.424–32.470; P = 0.016), procalcitonin (OR, 3.831; 95% CI: 0.551–27.027; P = 0.071), C-reactive protein (OR, 5.988; 95% CI: 1.179–30.300; P = 0.031) were significantly associated with the disease progression.

Multivariate logistic analysis indicated that age (odds ratio [OR], 8.546; 95% confidence interval [CI]: 1.628–44.864; P = 0.011), history of smoking (OR, 14.285; 95% CI: 1.577–25.000; P = 0.018), maximum body temperature at admission (OR, 8.999; 95% CI: 1.036–78.147, P = 0.046), respiratory failure (OR, 8.772, 95% CI: 1.942–40.000; P = 0.016), albumin (OR, 7.353, 95% CI: 1.098–50.000; P = 0.003), and C-reactive protein (OR, 10.530; 95% CI: 1.224−34.701, P = 0.028) were risk factors for disease progression.

Furthermore, the multivariate logistic analysis indicated that age (OR, 8.546; 95% CI: 1.628–44.864; P = 0.011), history of smoking (OR, 14.285; 95% CI: 1.577–25.000; P = 0.018), maximum body temperature at admission (OR, 8.999; 95% CI: 1.036–78.147, P = 0.046), respiratory failure (OR, 8.772, 95% CI: 1.942–40.000; P = 0.016), albumin (OR, 7.353, 95% CI: 1.098–50.000; P = 0.003) and C-reactive protein (OR, 10.53; 95% CI: 1.224–34.701, P = 0.028) were risk factors for disease progression [Table 4].",2020-05-12
0,2020-04-29,"Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China",10.1101/2020.04.24.20078063,medrxiv,HR 0.71,0.26,1.95,0.38,Not Significant,Not Adjusted,Extracted,,,,,,,,,Prospective observational study,114,"Union Hospital from January 23, 2020 to February 22, 2020",5/6/2020,Y,N,,,
1,2020-04-29,Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection,https://doi.org/10.1101/2020.04.24.20078006,medrxiv,OR 2.01,1.35,2.98,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,708,UK NHS hospital from 1st March to 5th April 2020,5/6/2020,Y,N,,,
2,2020-04-29,"Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.",https://doi.org/10.1101/2020.04.24.20077875,medrxiv,AOR: 1.2,0.64,2.24,0.57,Not Significant,Adjusted,Extracted,,,,,,,,,Retrospective observational study,610,"14 hospitals in Zhejiang province, China between Jan 10 and Feb 28, 2020 and confirmed diagnosis of Covid-19 infection were included",5/6/2020,N,N,,,
3,2020-04-28,Association of Digestive Symptoms and Hospitalization in Patients with SARS-CoV-2 Infection,https://doi.org/10.1101/2020.04.23.20076935,medrxiv,OR 4.42,1.54,12.63,0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,207,"Stanford University Hospital and Clinics from March 03, 2020 to April 7, 2020",5/6/2020,Y,N,,,
4,2020-04-28,"Clinical determinants for fatality of 44,672 patients with COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187660/,Critical Care,,,,,,,,RR 4.47,3.49,5.61,<0.01,Significant,Not Adjusted,"Extracted RR, Calculated OR",,Case series,44672,"Chinese center for disease control and prevention (44,672 laboratory confirmed cases updated through February 11, 2020, [2])",5/6/2020,N,N,,,
5,2020-04-28,"Predictive factors for disease progression in hospitalized patients with Coronavirus Disease 2019 in Wuhan, China",https://doi.org/10.1016/j.jcv.2020.104392,Journal of Clinical Virology,OR 17.6,4.84,63.98,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,111,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology from January 13 to February 16 in 2020",5/6/2020,Y,N,,,
6,2020-04-27,Estimating Survival of Hospitalized COVID-19 Patients from Admission Information,http://doi.org/10.1101/2020.04.22.20075416,medrxiv,,,,,,,,OR 1.59,1.38,1.83,<0.01,Significant,Not Adjusted,Calculated,,Retrospective observational study,5233,"Northwell Health acute care hospitals on or after March 1, 2020, and were discharged or died before April 12, 2020. Clinical outcomes (i.e., discharges, mortality, and length of stay) were monitored until April 12, 2020, the final date of follow-up",5/6/2020,N,Y,,,
7,2020-04-25,The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails,http://doi.org/10.1101/2020.04.21.20074633,,OR 3.54,1.79,7.01,,Significant,Not Adjusted,Extracted,,,,,,,,,Systematic review and meta-analysis,9 studies,"PubMed, Scopus, EMBASE, Web of Science, and Google Scholar searched through March 12 2021",5/6/2020,Y,N,,,
8,2020-04-25,Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up,10.1101/2020.04.21.20074641,medrxiv,,,,,,,,OR 1.39,0.73,2.64,0.29,Not Significant,Adjusted,Extracted,"Age, ICU admission, PCR test results, admission week, number of comorbidities, cardiovascular disease, chronic lung disease, gender, chronic kidney disease, immunodeficiency, hypertension",Retrospective observational study,1197,"Qazvin province hospitals Feb 20-March 11, 2020",5/6/2020,N,N,,,
9,2020-04-24,"COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes",https://doi.org/10.1101/2020.04.20.20072421,medrxiv,OR 2.17,0.69,6.83,0.19,Not Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,100,"YAS hospital affiliated to Tehran University of Medical Sciences from Feb 22 to March 5, 2020",5/6/2020,Y,N,,,
10,2020-04-23,Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis,https://doi.org/10.1016/j.jinf.2020.04.021,Journal of Infection,OR: 3.68,2.68,5.03,,Significant,Not Adjusted,Extracted,,,,,,,,,Systematic review and meta-analysis,3033 patients from 13 studies,China,5/6/2020,Y,N,,,
11,2020-04-23,"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy",doi.org/10.1016/j.thromres.2020.04.024,Thrombosis Research,OR 0.71,0.35,1.44,0.35,Not Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,388,"Humanitas Clinical and Research Hospital,  since February 2021",5/6/2020,Y,N,,,
12,2020-04-21,Epidemiological Characteristics of Coronavirus Disease 2019 (COVID-19) Patients in IRAN: A single Center Study [Journal of Clinical Virology],https://doi.org/10.1016/j.jcv.2020.104378,Journal of Clinical Virology,,,,,,,,OR 1.24,0.66,2.34,0.51,Not Significant,Not Adjusted,Calculated,,Retrospective observational study,2968,"Baqiyatallah hospital from 19 February 2020, to 15 April 2020",5/6/2020,N,N,,,
13,2020-04-20,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study",http://doi.org/10.1101/2020.04.15.20067157,medRxiv,,,,,,,,HR 0.89,0.57,1.39,,Not Significant,Not Adjusted,Extracted,,Prospective observational study,257,"Columbia University Irving Medical Center (2 affiliated hospitals in Manhattan) from March 2nd to April 1st, 2020.",5/6/2020,N,N,,,
14,2020-04-19,Early prediction of mortality risk among severe COVID-19 patients using machine learning,https://doi.org/10.1101/2020.04.13.20064329,medRxiv,,,,,,,,OR 1.16,0.55,2.47,0.7,Not Significant,Not Adjusted,Calculated,,Retrospective observational study,256,"Severe COVID-19 patients only from Sino-French New City Branch of Tongji Hospital from Jan 28 to March 11, 2020",5/6/2020,N,N,,,
15,2020-04-17,Clinical Characteristics of Covid-19 in New York City,10.1056/nejmc2010419,New England Journal of Medicine,OR 1.22,0.75,1.96,0.42,Not Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,393,"2 hospitals in Manhattan from March 3 - March 27, 2020",5/6/2020,Y,N,,,
16,2020-04-17,Association between ABO blood groups and clinical outcome of coronavirus disease 2019: Evidence from two cohorts,http://doi.org/10.1101/2020.04.15.20063107,medRxiv,,,,,,,,OR 1.5,0.53,4.27,0.45,Not Significant,Not Adjusted,Calculated,"age, sex, and medical history",Retrospective observational study,234,"Patients with mild symptoms from Xi’an, Beijing, and Wuhan and patients who are critically ill from Xi'an and Wuhan (from a total of 5 hospitals), enrolled from February 5 to March 20, 2025",5/6/2020,Y,N,,,
17,2020-04-17,"Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia â€“ A systematic review, meta-analysis, and meta-regression",https://doi.org/10.1016/j.dsx.2020.04.018,Diabetes & Metabolic Syndrome: Clinical Research & Reviews,RR 2.45,1.79,3.35,,Significant,Not Adjusted,Extracted,,,,,,,,,Systematic review and meta-analysis,30 studies enrolling 6452 patients,"PubMed and EuropePMC with the search terms (1) “COVID-19″ OR “SARS-CoV-2″ AND “Characteristics”, (2) “COVID-19″ OR “SARS-CoV-2″ AND “Diabetes”, English, MEDLINE through  April 8th, 2020.",5/6/2020,N,N,,,
18,2020-04-16,Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio,http://doi.org/10.1101/2020.04.13.20063545,,,,,,,,,HR 1.6,1.1,2.2,,Significant,Adjusted,Extracted,Age and gender,Retrospective observational study,2362,"All patients in Reggio Emilia, Italiy from Feb 27 to April 2, 2023",5/6/2020,N,N,,,
19,2020-04-16,Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio,https://doi.org/10.1101/2020.04.13.20063545,medRxiv,HR 1.5,1.3,1.9,,Significant,Not Adjusted,Extracted,HR 1.6,1.1,2.2,,Significant,Not Adjusted,Extracted,,Retrospective observational study,2653,"All symptomatic patients who tested positive in Reggio from February 27 to April 2, 2020.",5/6/2020,N,N,,,
20,2020-04-12,The clinical course and its correlated immune status in COVID-19 pneumonia,http://doi.org/10.1016/j.jcv.2020.104361,Journal of Clinical Virology,OR: 2.08,0.75,5.81,0.16,Not Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,204,"Renmin Hospital of Wuhan University between January 10.2020 and February 13,2020",5/6/2020,N,N,,,
21,2020-04-12,Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Risk factors for severity and mortality in adult COVID-19 1 inpatients in Wuhan,http://doi.org/10.1016/j.jaci.2020.04.006,Journal of Allergy and Clinical Immunology,OR 1.92,1.19,3.1,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,548,"Sino-French New City Branch of Tongji Hospital, Huazhong University of Science and 161 Technology in Wuhan from January 26, 2020 to February 5, 2022",5/6/2020,N,N,,,
22,2020-04-11,"Factors associated with hospitalization and critical illness among 4,103 patients with",http://doi.org/10.1101/2020.04.08.20057794,medRxiv,OR 1.14,0.83,1.58,0.41,Not Significant,Not Adjusted,Extracted,,,,,,,,,Cross-sectional study,4103,"Single-center study in  New York City between March 1, 2020 and April 2, 2020, with follow up through April 7, 2023",4/21/2020,Y,N,,,
23,2020-04-10,The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis,http://doi.org/10.1101/2020.04.08.20057539,medRxiv,OR: 2.95,1.44,6.03,<0.01,Significant,Not Adjusted,Extracted,,,,,,,,,Retrospective observational study,564,"Third Xiangya Hospital of Central South University, Changsha Public Health Treatment Center, First Hospital of Yueyang, Junshan People’s Hospital of Yueyang, Central Hospital of Shaoyang, Central Hospital of Xiangtan, Second Hospital of Changde, Central Hospital of Loudi, and First Affiliated Hospital of University of South China from January 17, 2020 to February 28, 2020.",4/20/2020,N,N,,,
24,2020-04-07,The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: A systematic review and meta-analysis,https://doi.org/10.1101/2020.04.05.20054155,medRxiv,RR 3.20,2.26,4.53,,Significant,Not Adjusted,Extracted,,,,,,,,,Systematic review and meta-analysis,11 studies enrolling 24403 patients,"PubMed and Embase were searched for records published between December 1, 2019 and March 20, 2020.",5/6/2020,Y,N,,,
25,2020-04-06,"Urinalysis, but not blood biochemistry, detects the early renal-impairment in patients with COVID-19",https://doi.org/10.1101/2020.04.03.20051722,medRxiv,OR 2.43,0.92,6.38,0.07,Not Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,178,"Tongji Medical College, Huazhong University of Science and Technology, from February 02 to February 29, 2020",5/6/2020,Y,N,,,
26,2020-04-03,History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study,https://doi.org/10.1101/2020.03.23.20041848,medRxiv,,,,,,,,HR 1.1,0.7,1.9,0.61,Not Significant,Not Adjusted,Extracted,,Retrospective observational study,275,"mainland China outside of Hubei Province, from December 18th, 2019 to March 8, 2026",4/10/2020,N,N,,,
27,2020-04-03,"Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep]",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119513/,Morbidity and Mortality Weekly Report,OR 4.67,3.85,5.66,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,7162,"CDC passive surveillance registry as of March 28, 2024",5/6/2020,Y,N,,,
28,2020-04-02,"Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort",10.1016/j.jinf.2020.04.020,Journal of Infection,,,,,,,,OR 3.95,1.4,11.16,0.01,Significant,Not Adjusted,Calculated,,Retrospective observational study,95,"North Bristol NHS Trust March 10 to March 30, 2020",5/6/2020,N,N,,,
29,2020-04-01,Risk factors for severe corona virus disease 2019 (COVID-19) patients : a systematic review and meta analysis,https://doi.org/10.1101/2020.03.30.20047415,medRxiv,OR 3.04,2.01,4.6,,Significant,Not Adjusted,Extracted,,,,,,,,,Systematic review and meta-analysis,10 studies enrolling 1083 patients,"China National Knowledge Infrastructure (CNKI), Wanfang, Weipu, Chinese Biomedicine Literature Database (CBM-SinoMed), MEDLINE (via PubMed), EMBASE, Cochrane Central Register and Web of science searched through  8 March 2020",5/6/2020,N,N,,,
30,2020-03-31,"Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis",https://doi.org/10.1101/2020.03.25.20043133,medRxiv,OR 2.67,1.91,3.74,<0.01,Significant,Not Adjusted,Extracted,,,,,,,,,Systematic review and meta-analysis,9 studies enrolling 1936 patients,"PubMed (1970-2020.03.06, English), Web of science (1950-2020.03.06, English), China National Knowledge Infrastructure Database (CNKI, 1979-2020.03.06, Chinese), WanFang Database (1970-2020.03.06, Chinese), and VIP Database (1970-2020.03.06, Chinese)",4/10/2020,N,N,,,
31,2020-03-31,Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up [Journal of Infection],https://doi.org/10.1016/j.jinf.2020.03.019,Journal of Infection,,,,,,,,HR 1.09,0.57,2.08,0.8,Not Significant,Not Adjusted,Extracted,"age, cardiovascular disease, cerebrovascular disease, COPD",Prospective observational study,339,"age over 60 years old admitted to Renmin Hospital of Wuhan University from Jan 1 to Feb 6, 2020 (followed up until March 5)",4/10/2020,N,N,,,
32,2020-03-30,"Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China",https://doi.org/10.1101/2020.03.25.20037721,medRxiv,AOR 3.11,1.16,8.37,<0.01,Significant,Adjusted,Extracted,,,,,,,,"neutrophil count, white blood cell count, hypersensitivie troponin I, diabetes, critical diagnosis, hypnotics, age >=65",Retrospective observational study,323,"Tianyou Hospital from January 8 to February 20, 2022",4/10/2020,N,N,,,
33,2020-03-30,"Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China",https://doi.org/10.1016/j.ijcard.2020.03.087,International Journal of Cardiology,OR 2.11,0.7,6.35,0.18,Not Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,112,"Renmin Hospital of Wuhan Univeristy from  January 6 to February 20, 2020",5/6/2020,N,N,,,
34,2020-03-30,Development and external validation of a prognostic multivariable model on admission for hospitalized patients with COVID-19,https://doi.org/10.1101/2020.03.28.20045997,medRxiv,,,,,,,,OR 1.65,0.9,3.0,0.1,Not Significant,Not Adjusted,Calculated,,Retrospective observational study,299,Tongji Hospital from Jan to Feb 2020,5/6/2020,N,Y,,,
35,2020-03-27,Predicting COVID-19 malignant progression with AI techniques,http://doi.org/10.1101/2020.03.20.20037325,medrxiv,OR 2.02,0.74,5.5,0.17,Not Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,133,"Wuhan Pulmonary Hospital from January 3 to February 13, 2024",5/6/2020,N,N,,,
36,2020-03-26,Comorbid Diabetes Mellitus was Associated with Poorer Prognosis in Patients with COVID-19: A Retrospective Cohort Study,https://doi.org/10.1101/2020.03.24.20042358,medRxiv,AHR 3.64,1.01,7.8,0.05,Not Significant,Adjusted,Extracted,AHR 3.64,1.09,12.21,0.04,Significant,Adjusted,Extracted,"Age, cardiovascular disease, chronic kidney disease, inflammatory biomarkers",Retrospective observational study,258,"West Court of Union Hospital of Huazhong University of Science and Technology admissions from  January 29 to February 12, 2020 (followed up through March 12)",4/10/2020,N,N,,,
37,2020-03-26,Comorbid Diabetes Mellitus was Associated with Poorer Prognosis in Patients with COVID-19: A Retrospective Cohort Study [medrxiv],https://doi.org/10.1101/2020.03.24.20042358,medRxiv,AOR: 2.37,1.25,4.5,0.01,Significant,Adjusted,Calculated,,,,,,,,,Retrospective observational study,258,"West Court of Union Hospital of Huazhong University of Science and Technology admissions from  January 29 to February 12, 2020 (followed up through March 12)",4/20/2020,Y,N,,,
38,2020-03-26,Comorbid Diabetes Mellitus was Associated with Poorer Prognosis in Patients with COVID-19: A Retrospective Cohort Study [medrxiv],https://doi.org/10.1101/2020.03.24.20042358,medRxiv,AOR: 1.37,0.74,2.55,0.32,Not Significant,Adjusted,Calculated,,,,,,,,,Retrospective observational study,258,"West Court of Union Hospital of Huazhong University of Science and Technology admissions from  January 29 to February 12, 2020 (followed up through March 12)",5/6/2020,Y,N,,,
39,2020-03-24,"Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: A single center retrospective cohort study",https://doi.org/10.1101/2020.03.21.20040121,medRxiv,,,,,,,Diabetes,OR 2.17,0.53,8.93,0.28,Not significant,Not Adjusted,Calculated,,Retrospective observational study,110,Patients from Wuhan No.1 Hospital from Dec 25th to Feb 15th.,4/10/2020,N,N,,,
40,2020-03-23,Prognostic value of C-reactive protein in patients with COVID-19,https://doi.org/10.1101/2020.03.21.20040360,medRxiv,,,,,,,,OR: 1.89,0.98,3.65,0.06,Not Significant,Not Adjusted,Calculated,,Retrospective observational study,298,"Eastern Campus of Renmin Hospital of Wuhan University from Jan 30 to Feb 20, 2026",4/10/2020,N,Y,,,
41,2020-03-23,"Clinical Characteristics of Coronavirus Disease 2019 in Hainan, China [medrxiv]",https://doi.org/10.1101/2020.03.19.20038539,medRxiv,OR: 6.13,1.82,20.7,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,168,Hainan province from 22 January 2020 to 14 March 2022,5/6/2020,N,N,,,
42,2020-03-23,"Clinical Characteristics of Coronavirus Disease 2019 in Hainan, China",https://doi.org/10.1101/2020.03.19.20038539,medRxiv,OR 6.13,1.82,20.69,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,168,Hainan province from 22 January 2020 to 14 March 2020,5/6/2020,N,N,,,
43,2020-03-20,"Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings",http://doi.org/10.1016/j.ijid.2020.03.040,International Journal of Infectious Diseases,OR 2.22,1.01,4.84,0.05,Significant,Not Adjusted,Extracted,,,,,,,,,Retrospective observational study,645,"Zhejiang from  Jan 17 to Feb 8, 2021",5/6/2020,N,N,,,
44,2020-03-18,Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081524/,Critical Care,OR 3.15,1.27,7.81,0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,487,"Zhejiang Province of China followed up until February 17, 2023",5/6/2020,N,N,,,
45,2020-03-17,"Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis",https://doi.org/10.1101/2020.03.17.20037572,medRxiv,OR 2.49,1.82,3.4,,Significant,Not Adjusted,Extracted,,,,,,,,Diabetes,Systematic review and meta-analysis,10 studies enrolling 2511 patients,"PubMed, Web of Science Core Collection, Embase, Cochrane and MedRxiv databases were searched through February 25, 2020.",4/10/2020,N,N,,,
46,2020-03-16,Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection [medrxiv],https://www.medrxiv.org/content/10.1101/2020.03.15.20035360v1.full.pdf,medRxiv,OR 3.12,1.0,9.75,0.05,Not Significant,Not Adjusted,Extracted,,,,,,,,,Systematic review and meta-analysis,4 studies enrolling 212 patients,"MEDLINE, EMBASE and Global Health, from 1st January 2019 to 5th March 2020",4/10/2020,N,N,,,
47,2020-03-16,"Influence factors of death risk among COVID-19 patients in Wuhan, China: a hospital-based case-cohort study",https://doi.org/10.1101/2020.03.13.20035329,medRxiv,,,,,,,Diabetes,RR 1.50,0.72,3.11,0.27,Not Significant,Not Adjusted,Extracted,,Retrospective observational study,200,"Union Hospital of Huazhong University of Science and Technology from Jan 1 to Jan 30, 2020",4/10/2020,N,N,,,
48,2020-03-16,Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection [medrxiv],https://www.medrxiv.org/content/10.1101/2020.03.15.20035360v1.full.pdf,medRxiv,OR 2.72,0.7,10.6,0.15,Not Significant,Not Adjusted,Extracted,,,,,,,,,Systematic review and meta-analysis,9 studies enrolling 212 patients,"MEDLINE, EMBASE and Global Health, from 1st January 2019 to 5th March 2020",4/15/2020,Y,N,,,
49,2020-03-13,"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China",https://doi.org/10.1001/jamainternmed.2020.0994,JAMA Internal Medicine,HR 2.34,1.35,4.05,<0.01,Significant,Not Adjusted,Extracted,HR 1.58,0.8,3.13,0.19,Not Significant,Not Adjusted,Extracted,,Retrospective observational study,201,"Wuhan Jinyintan Hospital in China from December 25, 2019 to January 26, 2020 (followed up through February 13, 2020)",4/10/2020,Y,N,,,
50,2020-03-12,"Dysregulation of immune response in patients with COVID-19 in Wuhan, China | Clinical Infectious Diseases | Oxford Academic [Clinical Infectious Diseases]",https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa248/5803306,Clincial Infectious Diseases,OR 1.49,0.87,2.55,0.15,Not Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,452,"Tongji hospital from Jan 10 to Feb 12, 2020.",5/6/2020,N,N,,,
51,2020-03-12,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",http://doi.org/10.1016/s0140-6736(20)30566-3,Lancet,,,,,,,,OR: 2.85,1.35,6.05,<0.01,Significant,Not Adjusted,Calculated,,Retrospective observational study,191,"Jinyintan Hospital and Wuhan Pulmonary Hospital (Wuhan, China) who had been discharged or had died by Jan 31, 2020",5/6/2020,N,Y,,,
52,2020-03-12,Dysregulation of immune response in patients with COVID-19 in Wuhan China,https://doi.org/10.1093/cid/ciaa248,Clinical Infectious Diseases,OR 2.61,1.5,4.52,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,452,"Tongji hospital, from January 10 to February 12, 2020",5/6/2020,N,N,,,
53,2020-03-11,Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China,https://doi.org/10.1007/s00392-020-01626-9,Clinical Research in Cardiology,RR: 2.21,0.88,5.57,0.09,Not Significant,Not Adjusted,Extracted,,,,,,,,,Systematic review and meta-analysis,5 studies enrolling 1514 patients,EMBASE and PubMed were searched from December 2019 to February 2020,5/6/2020,N,N,,,
54,2020-03-10,Prognostic value of NT-proBNP in patients with severe COVID-19,https://doi.org/10.1101/2020.03.07.20031575,Respiratory Research,,,,,,,,,,,,,,,,Retrospective observational study,54,Hubei General Hospital (followed for 15 days),4/10/2020,N,N,,,
55,2020-03-09,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",https://www.ncbi.nlm.nih.gov/pubmed/32171076,Lancet,,,,,,,,OR 2.85,1.35,6.05,<0.01,Significant,Not Adjusted,Calculated,,Retrospective observational study,191,"Only those who either died or were discharged, at Jinyintan Hospital or Wuhan Pulmonary Hospital through Jan 31, excluding those still hospitalized on Jan 31",4/10/2020,N,Y,,,
56,2020-03-06,Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-21,https://www.ncbi.nlm.nih.gov/pubmed/32141280,Chinese Journal of Cardiovascular Diseases,OR 1.95,0.63,5.99,0.25,Not Significant,Not Adjusted,Extracted,,,,,,,,,Cross-sectional study,150,"Tongji Hospital, excluding those with acute myocardial infarction",4/10/2020,N,N,,,
57,2020-03-06,"Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study",https://doi.org/10.1101/2020.03.03.20030353,medRxiv,OR 2.45,0.94,6.37,0.07,Not Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,291,"First Hospital of Changsha and Loudi Central Hospital from January 23 to February 14, 2020, followed up to Feb 20, 2020",5/6/2020,N,N,,,
58,2020-03-06,"Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study [medrxiv]",https://doi.org/10.1101/2020.03.03.20030355,medRxiv,OR 2.45,0.94,6.37,0.07,Not Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,291,"First Hospital of Changsha and Loudi Central Hospital from January 23 to February 14, 2020, followed up to Feb 20, 2023",5/6/2020,N,N,,,
59,2020-03-05,Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pubmed/32173574,International Journal of Infectious Diseases,OR 2.07,0.89,4.82,,Not Significant,Not Adjusted,Extracted,,,,,,,,,Systematic review and meta-analysis,4 studies enrolling 1138 subjects,"PubMed, EMBASE, and Web of Science published between Jan 1 and Feb 25 2020",4/10/2020,N,N,,,
60,2020-03-04,"Clinical findings in critically ill patients infected with SARS-CoV-2 in Guangdong Province, China: a multi-center, retrospective, observational study",https://doi.org/10.1101/2020.03.03.20030668,medRxiv,OR 1.10,0.3,4.02,0.88,Not Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,45,ICU admissions of 7 hospitals in Guangdong Province,4/10/2020,Y,N,,,
61,2020-03-03,"Clinical findings in critically ill patients infected with SARS-CoV-2 in Guangdong Province, China: a multi-center, retrospective, observational study",https://doi.org/10.1101/2020.03.03.20030668,medRxiv,OR 1.10 (95% CI: 0.30-4.02) p=0.88,,,,Not Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,45,ICU admissions of 7 hospitals in Guangdong Province,4/10/2020,Y,N,,,
62,2020-03-03,Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality China: a retrospective descriptive multiple-center study,https://doi.org/10.1101/2020.03.01.20029397,medRxiv,OR 4.58,1.97,10.66,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,267,"Qianjiang central hospital of Chongqing, Chongqing three gorges central hospital and Chongqing public health medical center from January 19 to February 16, 2024",5/6/2020,N,N,,,
63,2020-03-02,"Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China",https://doi.org/10.1101/2020.03.02.20030452,medRxiv,OR 1.47,0.57,3.81,0.43,Not Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,221,"Zhongnan Hospital of Wuhan University from January 2 to February 10, 2020 (followed-up through Feb 15)",4/10/2020,N,N,,,
64,2020-03-02,"Clinical Characteristics of Patients with Severe Pneumonia Caused by the 2019 Novel Coronavirus in Wuhan, China",https://doi.org/10.1101/2020.03.02.20029306,medRxiv,OR 2.48,0.82,7.46,0.11,Not Significant,Not Adjusted,Calculated,,,,,,,,,Cross-sectional study,110,"respiratory ICU admissions of Central Hospital of Wuhan from Jan 1-Feb 10, 2020",4/10/2020,N,N,,,
65,2020-02-28,Clinical Characteristics of Coronavirus Disease 2019 in China,https://www.ncbi.nlm.nih.gov/pubmed/32109013/,New England Journal of Medicine,OR 5.65,3.11,10.27,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,1099,"552 hospitals in China between Dec 11, 2020 to Jan 29, 2020",4/10/2020,Y,N,,,
66,2020-02-28,Clinical Characteristics of Coronavirus Disease 2019 in China,https://www.ncbi.nlm.nih.gov/pubmed/32109013/,New England Journal of Medicine,OR 3.18,1.95,5.19,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,1099,"552 hospitals in China between Dec 11, 2020 to Jan 29, 2020",4/10/2020,N,N,,,
67,2020-02-28,Prognostic impact of severe / critically severe new coronavirus pneumonia patients with myocardial injury,https://doi.org/10.3760/cma.j.cn112148-20200228-00137,Zhonghua xin xue guan bing za zhi,,,,,,,,OR 2.04,0.57,7.33,0.27,Not Significant,Not Adjusted,Calculated,,Retrospective observational study,54,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology from February 3 to February 24, 2020",5/6/2020,N,N,,,
68,2020-02-28,Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients [Zhonghua xin xue guan bing za zhi],https://www.ncbi.nlm.nih.gov/pubmed/32171190,Zhonghua Xin Xue Guan Bing Za Zhi.,,,,,,,,OR 2.04,0.57,7.33,0.27,Not Significant,Not Adjusted,Calculated,,Retrospective observational study,54,"Sino-French New City Hospital of Tongji Hospital from February 3, 2020 to February 24, 2020",5/6/2020,N,N,,,
69,2020-02-27,"Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis [medrxiv]",https://doi.org/10.1101/2020.02.25.20027664,medRxiv,HR 1.59,1.03,2.45,0.04,Significant,Not Adjusted,Extracted,,,,,,,,,Retrospective observational study,1590,"575 hospitals in China, from  November 21st, 2019 to January 31st, 2020",4/10/2020,Y,N,,,
70,2020-02-27,"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China",https://doi.org/10.1111/all.14238,Allergy,OR 1.30,0.47,3.59,0.62,Not Significant,Not Adjusted,Calculated,,,,,,,,,Cross-sectional study,140,"No. 7 Hospital in Wuhan from January 16 to February 3, 2020",4/10/2020,N,N,,,
71,2020-02-25,"Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study",https://doi.org/10.1101/2020.02.22.20026500,medRxiv,OR 1.52,0.7,3.3,0.29,Not Significant,Not Adjusted,Calculated,,,,,,,,,Case series,214,Union Hospital of Huazhong University of Science and Technology in Wuhan from 16 January to 19 February 2020,4/10/2020,N,N,,,
72,2020-02-23,"SARS-CoV-2 infection does not significantly cause acute renal injury: an analysis of 116 hospitalized patients with COVID-19 in a single hospital, Wuhan, China",https://doi.org/10.1101/2020.02.19.20025288,medRxiv,OR 1.36,0.49,3.73,0.55,Not Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,116,"Renmin Hospital of Wuhan University from January 14 to February 13, 2020",5/6/2020,N,N,,,
73,2020-02-23,ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan China,https://doi.org/10.1101/2020.02.20.20025510,medRxiv,OR 1.06,0.48,2.31,0.9,Not Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,577,"Wuhan Hankou Hospital from Jan 21 to Feb 5, 2020",5/6/2020,N,N,,,
74,2020-02-09,Clinical characteristics of 2019 novel coronavirus infection in China,https://doi.org/10.1101/2020.02.06.20020974,New England Journal of Medicine,OR 3.18,1.95,5.19,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,1099,"552 hospitals in China between Dec 11, 2020 to Jan 29, 2020",5/6/2020,N,N,,,
75,2020-02-08,"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",https://www.ncbi.nlm.nih.gov/pubmed/32031570,JAMA,OR 4.57,1.46,14.28,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Case series,138,"Zhongnan Hospital of Wuhan University from January 1 to January 28, 2020 (followed up through February 3)",4/10/2020,Y,N,,,
76,1905-07-12,Prognostic impact of severe / critically severe new coronavirus pneumonia patients with myocardial injury,https://doi.org/10.3760/cma.j.cn112148-20200228-00137,Zhonghua xin xue guan bing za zhi,,,,,,,,OR 2.04,0.57,7.33,0.27,Not Significant,Not Adjusted,Calculated,,Retrospective observational study,54,"Sino-French New City Campus of Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology from February 3, 2020 to February 24, 2020",5/6/2020,N,N,,,
